Male Central Precocious Puberty: Serum Profile of Anti-Müllerian Hormone and Inhibin B before, during, and after Treatment with GnRH Analogue

Table 1

Characteristics of boys with central precocious puberty included in this study.

	Age at diagnosis (years)	Bone age at diagnosis (years)	Peak LH at diagnosis (U/L)	Peak FSH at diagnosis (U/L)	Etiology	Age at GnRHa start (years)	Age at GnRHa end (years)
Patient 1	5.5	8.5	35.30	2.10	Idiopathic	5.6	8.9
Patient 2	4.3	8.5	6.90	0.70	Hypothalamic hamartoma	4.8	10.3
Patient 3	4.3	10.5	13.40	3.10	Hypothalamic hamartoma	4.3	9.8
Patient 4	1.7	3.6	37.00	2.30	Hypothalamic hamartoma	2.0	10.7
Patient 5	1.0	1.3	32.90	7.40	Idiopathic	2.2	N.A
Patient 6	0.8	2.0	84.90	1.70	Idiopathic	1.1	10.0

N.A: not applicable.